Market Closed -
Nyse
04:00:02 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
33.71
USD
|
+0.63%
|
|
+3.91%
|
-49.85%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
1,267
|
2,301
|
2,424
|
1,253
|
724.4
|
363.4
|
-
|
Enterprise Value (EV)
1 |
1,175
|
2,126
|
2,314
|
1,166
|
630
|
181
|
129.7
|
P/E ratio
|
17
x
|
22.6
x
|
15.1
x
|
9.06
x
|
7.39
x
|
17.7
x
|
10.8
x
|
Yield
|
-
|
2.3%
|
2.71%
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.78
x
|
2.46
x
|
1.59
x
|
0.78
x
|
0.68
x
|
0.52
x
|
0.48
x
|
EV / Revenue
|
1.65
x
|
2.27
x
|
1.52
x
|
0.73
x
|
0.59
x
|
0.26
x
|
0.17
x
|
EV / EBITDA
|
12.3
x
|
14.3
x
|
10.4
x
|
5.14
x
|
4.28
x
|
4.11
x
|
2.11
x
|
EV / FCF
|
15.8
x
|
15.3
x
|
38.4
x
|
6.55
x
|
-
|
4.61
x
|
2.58
x
|
FCF Yield
|
6.32%
|
6.55%
|
2.61%
|
15.3%
|
-
|
21.7%
|
38.8%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
11,564
|
11,718
|
11,574
|
10,865
|
10,777
|
10,782
|
-
|
Reference price
2 |
109.6
|
196.3
|
209.4
|
115.4
|
67.22
|
33.71
|
33.71
|
Announcement Date
|
2/26/20
|
2/25/21
|
2/23/22
|
2/21/23
|
2/20/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
713.7
|
934.8
|
1,526
|
1,599
|
1,072
|
694.4
|
755.8
|
EBITDA
1 |
95.66
|
148.5
|
223.1
|
227
|
147.1
|
44.05
|
61.5
|
EBIT
1 |
91.04
|
141.2
|
216.2
|
216
|
134
|
23.05
|
39.9
|
Operating Margin
|
12.76%
|
15.1%
|
14.17%
|
13.51%
|
12.5%
|
3.32%
|
5.28%
|
Earnings before Tax (EBT)
1 |
92.36
|
134.3
|
216.1
|
184.1
|
128.8
|
27.05
|
44.5
|
Net income
1 |
77.92
|
102.9
|
164
|
143.6
|
99.42
|
20.85
|
34.3
|
Net margin
|
10.92%
|
11%
|
10.75%
|
8.98%
|
9.27%
|
3%
|
4.54%
|
EPS
2 |
6.430
|
8.680
|
13.89
|
12.73
|
9.100
|
1.905
|
3.135
|
Free Cash Flow
1 |
74.2
|
139.3
|
60.34
|
177.9
|
-
|
39.25
|
50.3
|
FCF margin
|
10.4%
|
14.9%
|
3.95%
|
11.13%
|
-
|
5.65%
|
6.66%
|
FCF Conversion (EBITDA)
|
77.57%
|
93.83%
|
27.05%
|
78.38%
|
-
|
89.1%
|
81.79%
|
FCF Conversion (Net income)
|
95.23%
|
135.44%
|
36.78%
|
123.91%
|
-
|
188.25%
|
146.65%
|
Dividend per Share
|
-
|
4.520
|
5.680
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/26/20
|
2/25/21
|
2/23/22
|
2/21/23
|
2/20/24
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
413.4
|
377.8
|
417.6
|
453.3
|
390.4
|
337.2
|
349
|
296.2
|
235.9
|
191
|
168.9
|
175.1
|
176
|
174.4
|
177.4
|
EBITDA
1 |
57.81
|
46.37
|
57.53
|
61.12
|
52.09
|
56.22
|
64.49
|
42.07
|
28.92
|
19.58
|
13.8
|
14.3
|
9.45
|
6.45
|
13.85
|
EBIT
1 |
55.17
|
46.84
|
55.09
|
58.39
|
49.24
|
53.27
|
53.51
|
38.71
|
25.51
|
16.23
|
10.25
|
8.5
|
3.55
|
0.75
|
10.15
|
Operating Margin
|
13.35%
|
12.4%
|
13.19%
|
12.88%
|
12.61%
|
15.79%
|
15.33%
|
13.07%
|
10.81%
|
8.5%
|
6.07%
|
4.85%
|
2.02%
|
0.43%
|
5.72%
|
Earnings before Tax (EBT)
1 |
55.19
|
46.75
|
54.98
|
48.8
|
47.88
|
32.41
|
53.33
|
39.12
|
26.55
|
9.802
|
11.1
|
9.5
|
4.65
|
1.8
|
11.15
|
Net income
1 |
41.98
|
34.02
|
41.78
|
39.11
|
36.16
|
26.52
|
39.97
|
30.28
|
23.13
|
6.036
|
8.55
|
7.3
|
3.55
|
1.4
|
8.6
|
Net margin
|
10.16%
|
9%
|
10.01%
|
8.63%
|
9.26%
|
7.86%
|
11.45%
|
10.22%
|
9.81%
|
3.16%
|
5.06%
|
4.17%
|
2.02%
|
0.8%
|
4.85%
|
EPS
2 |
3.560
|
2.910
|
3.590
|
3.420
|
3.270
|
2.410
|
3.670
|
2.770
|
2.120
|
0.5500
|
0.7800
|
0.6650
|
0.3250
|
0.1300
|
0.7900
|
Dividend per Share
|
1.420
|
1.420
|
1.640
|
-
|
-
|
-
|
-
|
1.650
|
1.650
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/4/21
|
2/23/22
|
5/2/22
|
8/3/22
|
11/3/22
|
2/21/23
|
5/1/23
|
8/7/23
|
11/6/23
|
2/20/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
92.7
|
174
|
110
|
87.7
|
94.4
|
182
|
234
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
74.2
|
139
|
60.3
|
178
|
-
|
39.3
|
50.3
|
ROE (net income / shareholders' equity)
|
72.8%
|
78.5%
|
91.2%
|
80.3%
|
59%
|
9.6%
|
16.5%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
48.6%
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
337.2
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
10.1
|
5.89
|
34.2
|
16.7
|
-
|
9.9
|
11.2
|
Capex / Sales
|
1.41%
|
0.63%
|
2.24%
|
1.04%
|
-
|
1.43%
|
1.48%
|
Announcement Date
|
2/26/20
|
2/25/21
|
2/23/22
|
2/21/23
|
2/20/24
|
-
|
-
|
Last Close Price
33.71
USD Average target price
37.5
USD Spread / Average Target +11.24% Consensus |
1st Jan change
|
Capi.
|
---|
| -49.85% | 363M | | +8.20% | 7.78B | | +0.34% | 7.38B | | +10.20% | 6.52B | | -8.10% | 3.67B | | -13.13% | 3.44B | | -14.57% | 1.17B | | +8.34% | 934M | | -42.27% | 879M | | -18.90% | 836M |
Special Foods & Wellbeing Products
|